Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jun 25 · inside the Ichimoku cloud · RSI 43 · MACD below its signal
| 2.33 | 52-week high | +106.19% |
| 1.23 | Previous month high | +8.85% |
| 1.18 | Previous week high | +4.34% |
| 1.16 | R3 (classic) | +2.95% |
| 1.15 | R2 (classic) | +1.65% |
| 1.14 | R1 (classic) | +0.83% |
| 1.13 | Previous day high | +0.35% |
| 1.13 | Price now | |
| 1.12 | Pivot | −0.47% |
| 1.12 | S1 (classic) | −1.30% |
| 1.11 | Previous day low | −1.77% |
| 1.10 | S2 (classic) | −2.60% |
| 1.09 | S3 (classic) | −3.42% |
| 1.01 | Previous week low | −10.62% |
| 0.9840 | Previous month low | −12.92% |
| 0.9500 | 52-week low | −15.93% |
None of the 29 investors followed here reported a position in BON in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a BON trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for BON.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.0 | 1.8 | -24.1 | -1.0 | -0.8 | -5.1 | -8.5 | 3.6 | 5.3 | -5.8 | −28.9% | ||
| 2025 | -30.5 | -19.9 | -90.5 | -29.8 | -9.1 | -16.7 | 9.6 | 2.9 | 38.3 | -4.1 | -1.1 | -14.1 | −96.4% |
| 2024 | 2.2 | -15.6 | -11.8 | 6.1 | -37.0 | -12.0 | -16.1 | -9.4 | 6.0 | -29.2 | 15.9 | 10.6 | −67.2% |
| 2023 | 23.0 | 88.5 | -42.0 | -32.4 | -25.0 | -19.2 | 13.4 | -6.1 | -35.0 | 1.2 | 20.6 | 9.8 | −48.9% |
| 2022 | -25.4 | 17.8 | -7.7 | 42.9 | -16.3 | -36.6 | -37.2 | 23.8 | 1.5 | -35.3 | -30.7 | 9.0 | −76.2% |
| 2021 | 107.3 | -23.7 | -21.8 | -29.2 | -12.5 | -15.2 | −35.0% |
No analyst coverage for this instrument.
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.